PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
C Ryan Selected Research
SRL172
02/2005
Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control.
10/2000
A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
Articles by Research Topic
Disease
2
Mesothelioma
02/2006 - 10/2000
2
Small Cell Carcinoma
02/2005 - 10/2000
1
Syphilis
06/2007
1
Cytomegalovirus Infections (Inclusion Disease)
09/2005
1
Epistaxis (Nosebleed)
08/2002
1
Ulcerative Colitis
08/2001
1
Melanoma (Melanoma, Malignant)
08/2000
Drug/Important Bio-Agent (IBA)
2
SRL172
IBA
02/2005 - 10/2000
1
valganciclovir
FDA Link
09/2005
1
sildenafil (Viagra)
FDA Link
08/2002
1
infliximab (Remicade)
FDA Link
08/2001
1
Interferons
IBA
08/2000
Therapy/Procedure
3
Drug Therapy (Chemotherapy)
02/2006 - 10/2000
1
Prenatal Care
06/2007
1
Transplantation (Transplant Recipients)
09/2005